KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xenon Pharmaceuticals (XENE) Prepaid Assets: 2013-2024

Historic Prepaid Assets for Xenon Pharmaceuticals (XENE) over the last 11 years, with Dec 2024 value amounting to $6.9 million.

  • Xenon Pharmaceuticals' Prepaid Assets rose 264.00% to $17.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.1 million, marking a year-over-year increase of 264.00%. This contributed to the annual value of $6.9 million for FY2024, which is 14.72% up from last year.
  • Latest data reveals that Xenon Pharmaceuticals reported Prepaid Assets of $6.9 million as of FY2024, which was up 14.72% from $6.0 million recorded in FY2023.
  • Xenon Pharmaceuticals' 5-year Prepaid Assets high stood at $7.2 million for FY2022, and its period low was $3.0 million during FY2020.
  • For the 3-year period, Xenon Pharmaceuticals' Prepaid Assets averaged around $6.7 million, with its median value being $6.9 million (2024).
  • As far as peak fluctuations go, Xenon Pharmaceuticals' Prepaid Assets skyrocketed by 61.24% in 2022, and later decreased by 16.87% in 2023.
  • Yearly analysis of 5 years shows Xenon Pharmaceuticals' Prepaid Assets stood at $3.0 million in 2020, then surged by 51.18% to $4.5 million in 2021, then surged by 61.24% to $7.2 million in 2022, then fell by 16.87% to $6.0 million in 2023, then rose by 14.72% to $6.9 million in 2024.